[Association between serum cortisol levels and multiple organ dysfunction in neonates with perinatal asphyxia].

IF 0.9 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL
Ramóna Kerekes, Marianna Dobi, Ágnes Jermendy, Miklós Szabó, Kata Kovács
{"title":"[Association between serum cortisol levels and multiple organ dysfunction in neonates with perinatal asphyxia].","authors":"Ramóna Kerekes, Marianna Dobi, Ágnes Jermendy, Miklós Szabó, Kata Kovács","doi":"10.1556/650.2025.33317","DOIUrl":null,"url":null,"abstract":"<p><p>Introduction: Therapy-resistant hypotension is observed in 16% of neonates with perinatal asphyxia undergoing therapeutic hypothermia. Relative adrenal insufficiency, defined by an inadequate cortisol response to stress, is a potential etiological factor. Hydrocortisone supplementation may be the causal treatment; however, optimal dosing during hypothermia remains unknown. Serum cortisol levels may serve as a useful marker for monitoring treatment, although these levels are likely influenced by multiorgan dysfunction secondary to the hypoxic injury and by the effects of hypothermia on drug metabolism. Objective: The aim of our research was to evaluate serum cortisol levels in cooled neonates with perinatal asphyxia before and during hydrocortisone supplementation, and to investigate the association between these levels and the severity of multiorgan dysfunction. Method: This retrospective cohort study included neonates with perinatal asphyxia treated with therapeutic hypothermia and hydrocortisone supplementation at the Neonatal Intensive Care Unit, Pediatric Center, Semmelweis University between January 2007 and December 2022. We assessed serum cortisol levels and parameters indicating the severity of multiorgan dysfunction. Results: Data from 44 neonates (126 cortisol samples) were analyzed. Two-thirds of the endogenous serum cortisol levels were below the diagnostic threshold for relative adrenal insufficiency (15 µg/dl), with a median of 4.6 µg/dl [IQR 2.8; 17.1]. Hydrocortisone supplementation resulted in a significant elevation in cortisol levels (median 61.2 µg/dl [30.6; 93.4], p<0.001), which continued to rise during therapy (median 77.6 µg/dl [46.1; 171.3], p = 0.002). Newborns with more severe multiorgan dysfunction had significantly higher cortisol levels before and after hydrocortisone supplementation. Discussion: In neonates undergoing therapeutic hypothermia after perinatal asphyxia, low serum cortisol levels can be increased by hydrocortisone supplementation in cases of suspected relative adrenal insufficiency. The higher cortisol levels observed in cases of severe multiorgan dysfunction may result from increased hormone secretion, as well as reduced drug metabolism and excretion. Conclusion: Optimizing hydrocortisone therapy is crucial in the management of cooled neonates with perinatal asphyxia. Prospective pharmacokinetic studies considering the severity of multiorgan dysfunction should be conducted. Orv Hetil. 2025; 166(24): 942–952.</p>","PeriodicalId":19911,"journal":{"name":"Orvosi hetilap","volume":"166 24","pages":"942-952"},"PeriodicalIF":0.9000,"publicationDate":"2025-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Orvosi hetilap","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1556/650.2025.33317","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Therapy-resistant hypotension is observed in 16% of neonates with perinatal asphyxia undergoing therapeutic hypothermia. Relative adrenal insufficiency, defined by an inadequate cortisol response to stress, is a potential etiological factor. Hydrocortisone supplementation may be the causal treatment; however, optimal dosing during hypothermia remains unknown. Serum cortisol levels may serve as a useful marker for monitoring treatment, although these levels are likely influenced by multiorgan dysfunction secondary to the hypoxic injury and by the effects of hypothermia on drug metabolism. Objective: The aim of our research was to evaluate serum cortisol levels in cooled neonates with perinatal asphyxia before and during hydrocortisone supplementation, and to investigate the association between these levels and the severity of multiorgan dysfunction. Method: This retrospective cohort study included neonates with perinatal asphyxia treated with therapeutic hypothermia and hydrocortisone supplementation at the Neonatal Intensive Care Unit, Pediatric Center, Semmelweis University between January 2007 and December 2022. We assessed serum cortisol levels and parameters indicating the severity of multiorgan dysfunction. Results: Data from 44 neonates (126 cortisol samples) were analyzed. Two-thirds of the endogenous serum cortisol levels were below the diagnostic threshold for relative adrenal insufficiency (15 µg/dl), with a median of 4.6 µg/dl [IQR 2.8; 17.1]. Hydrocortisone supplementation resulted in a significant elevation in cortisol levels (median 61.2 µg/dl [30.6; 93.4], p<0.001), which continued to rise during therapy (median 77.6 µg/dl [46.1; 171.3], p = 0.002). Newborns with more severe multiorgan dysfunction had significantly higher cortisol levels before and after hydrocortisone supplementation. Discussion: In neonates undergoing therapeutic hypothermia after perinatal asphyxia, low serum cortisol levels can be increased by hydrocortisone supplementation in cases of suspected relative adrenal insufficiency. The higher cortisol levels observed in cases of severe multiorgan dysfunction may result from increased hormone secretion, as well as reduced drug metabolism and excretion. Conclusion: Optimizing hydrocortisone therapy is crucial in the management of cooled neonates with perinatal asphyxia. Prospective pharmacokinetic studies considering the severity of multiorgan dysfunction should be conducted. Orv Hetil. 2025; 166(24): 942–952.

[围产期窒息新生儿血清皮质醇水平与多器官功能障碍的关系]。
导读:16%的围产期窒息新生儿接受治疗性低温治疗后出现治疗抵抗性低血压。相对肾上腺功能不全,即皮质醇对压力的反应不足,是一个潜在的病因。补充氢化可的松可能是因果治疗;然而,低温期间的最佳剂量仍然未知。血清皮质醇水平可以作为监测治疗的有用标记,尽管这些水平可能受到继发于缺氧损伤的多器官功能障碍和低温对药物代谢的影响。目的:本研究的目的是评估围生期窒息新生儿在补充氢化可的松前和补充氢化可的松期间的血清皮质醇水平,并探讨这些水平与多器官功能障碍严重程度的关系。方法:本回顾性队列研究纳入2007年1月至2022年12月在Semmelweis大学儿科中心新生儿重症监护病房接受治疗性低温和补充氢化可的松治疗的围产期窒息新生儿。我们评估了血清皮质醇水平和指示多器官功能障碍严重程度的参数。结果:对44例新生儿126例皮质醇样本进行数据分析。三分之二的内源性血清皮质醇水平低于相对肾上腺功能不全的诊断阈值(15微克/分升),中位数为4.6微克/分升[IQR 2.8;17.1]。补充氢化可的松导致皮质醇水平显著升高(中位数为61.2µg/dl [30.6;93.4], p
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Orvosi hetilap
Orvosi hetilap MEDICINE, GENERAL & INTERNAL-
CiteScore
1.20
自引率
50.00%
发文量
274
期刊介绍: The journal publishes original and review papers in the fields of experimental and clinical medicine. It covers epidemiology, diagnostics, therapy and the prevention of human diseases as well as papers of medical history. Orvosi Hetilap is the oldest, still in-print, Hungarian publication and also the one-and-only weekly published scientific journal in Hungary. The strategy of the journal is based on the Curatorium of the Lajos Markusovszky Foundation and on the National and International Editorial Board. The 150 year-old journal is part of the Hungarian Cultural Heritage.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信